337 related articles for article (PubMed ID: 14702530)
1. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury.
Fuller TF; Freise CE; Serkova N; Niemann CU; Olson JL; Feng S
Transplantation; 2003 Dec; 76(11):1594-9. PubMed ID: 14702530
[TBL] [Abstract][Full Text] [Related]
2. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
3. A modified University of Wisconsin preservation solution with high-NA+ low-K+ content reduces reperfusion injury of the pig kidney graft.
Hauet T; Han Z; Doucet C; Ramella-Virieux S; Hadj Aïssa A; Carretier M; Papadopoulos V
Transplantation; 2003 Jul; 76(1):18-27. PubMed ID: 12865781
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury.
Hauet T; Baumert H; Gibelin H; Hameury F; Goujon JM; Carretier M; Eugene M
Cryobiology; 2000 Dec; 41(4):280-91. PubMed ID: 11222025
[TBL] [Abstract][Full Text] [Related]
5. Insulin in University of Wisconsin solution exacerbates the ischemic injury and decreases the graft survival rate in rat liver transplantation.
Li XL; Man K; Liu YF; Lee TK; Tsui SH; Lau CK; Lo CM; Fan ST
Transplantation; 2003 Jul; 76(1):44-9. PubMed ID: 12865784
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus in kidney transplant donors and clinical and histologic improvement in recipients: rat model.
Cicora F; Lausada N; Vasquez DN; Cicora P; Zalazar G; Gonzalez P; Palti G; Raimondi C
Transplant Proc; 2010; 42(1):365-70. PubMed ID: 20172351
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of trimetazidine in renal dysfunction secondary to cold ischemia-reperfusion injury: a proposed addition to University of Wisconsin solution.
Hauet T; Tallineau C; Goujon JM; Carretier M; Eugene M; Tillement JP
Cryobiology; 1998 Nov; 37(3):231-44. PubMed ID: 9787068
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Vasosol and University of Wisconsin solutions on early kidney function after 24 hours of cold ischemia in a canine autotransplantation model.
Polyak MM; Grosche A
J Surg Res; 2008 Dec; 150(2):255-60. PubMed ID: 18561949
[TBL] [Abstract][Full Text] [Related]
9. Perfluorocarbon improves post-transplant survival and early kidney function following prolonged cold ischemia.
Marada T; Zacharovova K; Saudek F
Eur Surg Res; 2010; 44(3-4):170-8. PubMed ID: 20339301
[TBL] [Abstract][Full Text] [Related]
10. Influence of retrieval conditions on renal medulla injury: evaluation by proton NMR spectroscopy in an isolated perfused pig kidney model.
Hauet T; Gibelin H; Richer JP; Godart C; Eugene M; Carretier M
J Surg Res; 2000 Sep; 93(1):1-8. PubMed ID: 10945936
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury.
Abe T; Li XK; Yazawa K; Hatayama N; Xie L; Sato B; Kakuta Y; Tsutahara K; Okumi M; Tsuda H; Kaimori JY; Isaka Y; Natori M; Takahara S; Nonomura N
Transplantation; 2012 Jul; 94(1):14-21. PubMed ID: 22683850
[TBL] [Abstract][Full Text] [Related]
12. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
Hsu HJ; Tian YC; Chen YC; Lai BC; Fang JT; Yang CW; Wu MS
Ren Fail; 2008; 30(3):303-6. PubMed ID: 18350450
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of conversion to sirolimus in 85 renal transplant recipients.
Sola E; Lopez V; Gutierrez C; Cabello M; Burgos D; Gonzalez Molina M; Hernandez D
Transplant Proc; 2009; 41(6):2137-8. PubMed ID: 19715855
[TBL] [Abstract][Full Text] [Related]
14. Glutathione supplementation during cold ischemia does not confer early functional advantage in renal transplantation.
Polyak MM; Arrington BO; Kapur S; Stubenbord WT; Kinkhabwala M
Transplantation; 2000 Jul; 70(1):202-5. PubMed ID: 10919601
[TBL] [Abstract][Full Text] [Related]
15. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
[TBL] [Abstract][Full Text] [Related]
17. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
Boratynska M; Banasik M; Patrzalek D; Klinger M
Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
19. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury.
Gonçalves GM; Cenedeze MA; Feitoza CQ; de Paula CB; Marques GD; Pinheiro HS; de Paula Antunes Teixeira V; Antônia dos Reis M; Pacheco-Silva A; Câmara NO
Transplant Proc; 2007 Mar; 39(2):417-20. PubMed ID: 17362745
[TBL] [Abstract][Full Text] [Related]
20. The effect of sirolimus in the development of chronic allograft nephropathy.
Gürkan A; Kaçar S; Erdoğdu U; Varilsüha C; Kandemir G; Karaca C; Akman F
Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
